Systasy Bioscience

Systasy is a well-established biotechnology company specializing in automated induced pluripotent stem cell (iPSC) solutions, with a focus on complex diseases, particularly brain-related disorders. Leveraging highly multiplexed pathway activity screening technologies and patient-derived human disease models, Systasy deciphers complex diseases. Additionally, Systasy's platform extracts AI-driven unique insights from human biology to generate ultra-large-scale, high-quality data, such as AI-powered patient stratification, and AI-driven biomarker prediction, identification, and validation. The company also offers viral tropism analysis services for gene therapy development. Systasy’s vision is to discover breakthrough therapies to transform the lives of patients with brain diseases. By integrating patient-derived cellular disease models, pathway monitoring, and therapeutic testing, Systasy aims to significantly increase the success rate of drug discovery and revolutionize the treatment of brain diseases.